Intermittent micafungin dosing schedule in pediatric oncology patients ‐ safe for outpatient parenteral antimicrobial therapy?
Introduction: Antifungal prophylaxis is an important preventative strategy for high-risk pediatric oncology patients. When triazoles are contraindicated, micafungin is an alternative to polyenes, due to improved tolerability and limited drug-drug interactions. An intermittent dosing schedule is adva...
Saved in:
Main Authors: | Jade A. Fox, Nicolette Graham, Rachael Lawson, Sonya Stacey, Julia E. Clark |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | EJC Paediatric Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X24000497 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Physicochemical characterization of micafungin and anidulafungin for its nebulized administration
by: Sonia Terradas-Campanario, et al.
Published: (2019-09-01) -
COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE
by: Jean Elcheikh
Published: (2015-08-01) -
Tracheobronchial mucormycosis successfully treated with venous-venous extracorporeal membrane oxygenation combined with prolonged amphotericin B instillation by Bronchoscopy: a case report
by: Ying Xu, et al.
Published: (2024-11-01) -
Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit
by: Niki Dermitzaki, et al.
Published: (2024-12-01) -
Effects of Different Concentrations of AmB on the Unsaturated Phospholipid–Cholesterol Membrane Using the Langmuir Monolayer and Liposome Models
by: Juan Wang, et al.
Published: (2024-11-01)